The Dental AI Buyer's Guide: How to Choose Between Pearl, Overjet, and VideaHealth
Dental AI has moved from pilot to procurement. DSOs and group practices are no longer asking whether to adopt — they are asking which platform to standardize...
Dental AI has moved from pilot to procurement. DSOs and group practices are no longer asking whether to adopt — they are asking which platform to standardize across hundreds of chairs. That question has no universal answer. Three companies now dominate the evaluation shortlist, and each has built a fundamentally different product.
This dental AI buyer's guide compares Pearl, Overjet, and VideaHealth across the dimensions that matter when you are signing multi-year contracts: product scope, regulatory positioning, DSO fit, integration depth, and transparency. If you are choosing a dental AI platform for a DSO or multi-location practice, this DSO AI platform guide helps you structure that decision. Pearl vs Overjet vs VideaHealth is not a question of which is best — it is a question of which fits your organization's scale, workflow, and integration capacity.
Market Context
Dental AI adoption is accelerating for three concrete reasons. First, FDA-clearance pathways for dental AI diagnostics have matured — Overjet's 47 FDA mentions on their own site reflect how central regulatory status has become to vendor positioning. Second, DSO consolidation has created enough operational scale to justify multi-year platform investments. A 50-location DSO can amortize integration costs across hundreds of chairs; a single practice cannot. Third, the product category itself has widened. What was once "caries detection on bitewing radiographs" is now a full-stack proposition — diagnostics, revenue cycle management, voice documentation, alignment monitoring, and practice management. Pearl's expansion from one product to six in roughly two years is the clearest example of this shift.
The procurement reality is that dental organizations are now choosing not whether to standardize on a platform, but which platform will hold their AI standard for the next three to five years. That decision is expensive to reverse. Integration investment, staff training, protocol development, and workflow change are all sunk costs once you commit. The process of choosing dental AI platform infrastructure should not be rushed — this guide exists to make that commitment easier to evaluate.
The Three Competitors
Pearl: The Ecosystem Play
Pearl has expanded beyond diagnostic AI into a six-product suite: Second Opinion 3D (radiographic detection), Calibrate (alignment monitoring), RCM (revenue cycle management), Voice (ambient clinical documentation), Practice AI (practice management), and the base platform. This is no longer a single-product company. It is a full dental AI stack.
That breadth is the central argument for Pearl. A DSO that adopts Pearl gets diagnostics, alignment, billing, voice, and practice management under one vendor — fewer integration projects, one contracting relationship, unified support. The tradeoff is complexity. Six products means six things to deploy, train staff on, and maintain. For organizations that want one vendor for everything, Pearl is the only option on this list that qualifies.
Pearl's customer footprint includes PDS Health and Coast Dental, both visible on their homepage. The company raised a $58M Series C and is deploying it through partnerships rather than press releases — their last formal announcement was the Ambient Voice AI Suite in April 2026, and they have been quiet on PR since, though blog activity continues through mid-July. The funding is being put to work operationally, not promotionally.
Best fit: DSOs that want a single-vendor AI stack and have the integration capacity to support six products.
Overjet: The Enterprise DSO Standard
Overjet's positioning is built on two numbers: 125 DSO mentions on their homepage and 47 FDA references. The FDA positioning has strengthen — up from 32 mentions the prior week. For DSOs operating across multiple states with varying regulatory environments, FDA clearance is not a vanity metric. It is a procurement requirement that shortlists vendors.
Overjet raised a $138M Series D and targets the enterprise DSO and payer segments — their site explicitly calls itself "The #1 Dental AI Platform for Providers & Payers." The payer angle is significant. If your organization involves dental insurance administration or claims adjudication alongside clinical operations, Overjet is the only platform here built to serve both sides of that workflow.
The company's content footprint is large (365KB homepage, JS-rendered via Storyblok CMS) and heavily DSO-focused. Overjet is doing enterprise DSO work below the press-release radar — the scale of their DSO deployment may be larger than their public announcements suggest.
Best fit: Enterprise DSOs that need FDA-cleared diagnostics and want a platform that serves both clinical and payer workflows.
VideaHealth: The DSO Assistant
VideaHealth was incorrectly assessed as dead for multiple weeks. It is not. The company has a live, 230KB marketing website at videa.ai with a 27KB sitemap, DSO customer testimonials, and a named partnership with Independence Dental. Their homepage headline reads "Dental AI Assistant for DSOs & Practices," and their stated philosophy is "Less complexity, better care."
VideaHealth's positioning is simplicity. Where Pearl builds a six-product ecosystem and Overjet builds an enterprise regulatory platform, VideaHealth focuses on being the dental AI assistant — a lower-friction entry point for DSOs that want diagnostic AI without a full platform migration. The Independence Dental partnership is proof that real DSO customers are deploying this product.
The company is active and targeting the DSO market. Any buyer's guide that omits VideaHealth is working from stale intelligence.
Best fit: DSOs and group practices that want diagnostic AI deployment without ecosystem complexity — particularly mid-market organizations evaluating their first AI platform.
Evaluation Framework
Use these five dimensions when comparing platforms for your organization. Not all carry equal weight for every buyer — rank them by your own constraints before starting vendor conversations.
1. Diagnostic Accuracy and Coverage
What modalities does the AI analyze (bitewing, panoramic, CBCT, intraoral)? What is the detection sensitivity and specificity? Is the AI trained on diverse populations and sensor types? FDA clearance matters here — it means the AI has been evaluated for safety and efficacy, not just trained on a dataset. Overjet's 47 FDA mentions signal investment in this area. Pearl's Second Opinion 3D has clearance for radiographic detection. Ask vendors for peer-reviewed validation studies and head-to-head performance data, not just marketing claims.
2. Integration Depth
Does the platform integrate with your practice management system (Dentrix, Eaglesoft, OpenDental, Curve)? Does it integrate with your imaging software (Apteryx, Dexis, Carestream)? Integration determines whether AI results show up in the clinical workflow where decisions are actually made, or in a separate dashboard no one checks. Pearl's six-product suite covers PMS, RCM, and voice — broad integration by definition, since the products ARE the integrations. Overjet and VideaHealth focus on imaging workflow integration specifically.
3. DSO Scalability
Can the platform deploy across hundreds of locations with centralized configuration? Does it support multi-location analytics, standardized protocols, and group-level reporting? DSO-specific features matter — single-practice AI is a different product class. Overjet's 125 DSO mentions and Pearl's PDS Health and Coast Dental partnerships both indicate proven DSO deployment. VideaHealth's Independence Dental partnership confirms DSO capability, though at a different scale than the enterprise players.
4. Pricing Transparency
What does deployment cost per location, per provider, per month? Is pricing published or quote-only? What is the implementation fee? Are there integration costs on top of licensing? Pricing opacity is a red flag — vendors that refuse to publish pricing are often pricing discriminatorily based on organization size. None of these three platforms publish public pricing, so this dimension requires direct outreach. Ask for a written quote with a multi-year cost projection before evaluating further.
5. Support and Training
What does onboarding look like? How many hours of training are included? Is there a dedicated customer success manager for DSO accounts? What is the response time SLA for production issues? AI platforms that go unused because staff were not trained properly are a sunk cost. Pearl's ecosystem model implies more training surface area (six products). VideaHealth's simplicity-focused positioning implies less. Verify both assumptions with reference calls.
Common Pitfalls
Choosing the platform with the most features. Six products sounds better than three until you have to deploy, integrate, and train staff on all six. Feature count is not value. Match product scope to your actual workflow gaps.
Prioritizing FDA clearance when you do not need it. FDA clearance is essential for clinical diagnostic claims and for organizations operating in regulated multi-state environments. If your use case is supporting clinical workflow (not autonomous diagnosis), a cleared platform may be over-procured for your needs. Know which you are buying.
Ignoring the payer side. If your organization involves claims adjudication or dental insurance administration alongside clinical operations, most platforms on this list will not serve that workflow. Overjet is the only one built for the payer side. This is a binary filter — not a nice-to-have.
Evaluating in isolation. Do not evaluate a platform without reference calls to at least two current DSO customers at comparable scale. Every platform on this list has public partnerships. Call them. Ask what broke during deployment and how long it took to fix.
Underestimating integration time. Dental AI is not a SaaS login. It requires imaging software integration, PMS integration, staff training, and protocol development. Budget 90-120 days from contract to production rollout for a single-location pilot, and 6-12 months for DSO-wide deployment.
Treating "dental AI comparison" as a spec sheet exercise. Dental AI software evaluation is not a feature matrix. Two platforms with identical checkmarks perform differently in production because of training data diversity, sensor compatibility, edge case handling, and the quality of the clinical workflow integration. The feature list gets you to the demo. The demo and the reference calls get you to the contract.
How to Run a Pilot
A 90-day pilot at one or two locations is the right way to validate any platform on this list. Structure it as follows:
Days 1-15: Integration and configuration. Get the AI connected to your imaging software and PMS. Configure detection thresholds to match your clinical protocols. This is where most integrations stall — if the vendor cannot complete this in 15 days for a single location, that is a signal about what DSO-wide rollout will look like.
Days 16-45: Clinical evaluation. Run AI alongside your existing workflow without changing clinician behavior. Measure detection agreement between AI findings and clinician findings. Track false positives — they erode clinician trust faster than missed detections erode patient outcomes. Ask the vendor for their published sensitivity and specificity numbers and compare them to what you observe.
Days 46-75: Workflow integration. Begin using AI results in clinical decision-making. Train staff on the protocol. Document where the AI adds value and where it creates friction. This is the phase that separates platforms that integrate into workflow from platforms that sit in a separate dashboard nobody opens.
Days 76-90: Decision. Evaluate detection performance, workflow fit, staff adoption, and vendor responsiveness. Decide whether to proceed to DSO-wide deployment or re-evaluate. Do not extend a pilot indefinitely — a platform that cannot prove value in 90 days will not prove value in 180.
Decision Checklist
Before signing a contract, answer these questions:
- [ ] What specific workflow problem are we solving? (Write it down in one sentence.)
- [ ] Which modalities do we need AI to analyze?
- [ ] Does the platform integrate with our existing PMS and imaging software?
- [ ] Do we need FDA-cleared diagnostics, or clinical workflow support?
- [ ] Does our organization involve payer workflows that the platform must support?
- [ ] What is the total cost over 3 years, including implementation and integration?
- [ ] How many DSOs at comparable scale have deployed this platform? Can we call two?
- [ ] What does the training program look like, and how is it delivered across hundreds of locations?
- [ ] What is the exit strategy if the platform underperforms?
Quick Reference
| Dimension | Pearl | Overjet | VideaHealth |
|---|---|---|---|
| Product scope | 6-product ecosystem | Enterprise diagnostic + payer | DSO assistant (simplicity) |
| Key customers | PDS Health, Coast Dental | Enterprise DSOs (unnamed at scale) | Independence Dental |
| FDA positioning | Second Opinion 3D cleared | 47 FDA mentions, core positioning | Not prominently positioned |
| DSO scale signal | Multi-product DSO suite | 125 DSO mentions on homepage | Named DSO partnership |
| Funding | $58M Series C | $138M Series D | Not publicly disclosed |
| Payer workflow | No | Yes (providers & payers) | No |
| Integration breadth | widest (6 products = 6 integration surfaces) | Imaging + payer systems | Imaging workflow focused |
| Best for | DSOs wanting one vendor for everything | Enterprise DSOs needing FDA + payer | Mid-market DSOs wanting simple AI |
You built it. We optimize it.
OralMind helps dental organizations evaluate, deploy, and scale AI platforms across multi-location practices. Book a consultation.